- Telehealth visits
Rosanna Wustrack, MD
Orthopedic Surgery • Orthopedic Surgery (Bone and Soft Tissue Tumors)- Telehealth visits
Rosanna Wustrack, MD
Orthopedic Surgery • Orthopedic Surgery (Bone and Soft Tissue Tumors)- Telehealth visits
On this page
About me
Dr. Rosanna Wustrack is an orthopedic surgeon who specializes in diagnosing and treating patients with musculoskeletal tumors and fragility fractures (breaks that happen during normal activities because bones have become weak).
In research, Wustrack's interests include functional outcomes in cancer patients, osseointegration (bone growth that serves to secure a surgical implant) and optimizing treatment for patients when cancer has spread in the body. She also studies osteoporosis in cancer survivors as well as issues related to global health.
Wustrack earned her medical degree from Washington University School of Medicine in St. Louis. She completed a residency in orthopedic surgery at UCSF and fellowship training in musculoskeletal oncology at Memorial Sloan Kettering Cancer Center.
Education & training
Board certification
- Orthopaedic Surgery, American Board of Orthopaedic Surgery
Fellowship
- Orthopaedic Surgery, Memorial Sloan-Kettering Cancer Center
Residency
- Orthopaedic Surgery, UCSF Medical Center - OMAG
Internship
- Orthopaedic Surgery, UCSF Medical Center - OMAG
Degree
- MD, Washington University School of Medicine in St. Louis
Academic Title
- Clinical Professor
My expertise
Specialties
- Orthopedic Surgery
- Orthopedic Surgery (Bone and Soft Tissue Tumors)
- Surgical Oncology (Sarcoma)
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.